138 related articles for article (PubMed ID: 38663257)
1. Exploration of TCM syndrome types of the material basis and risk prediction of Wilson disease liver fibrosis based on
Chen H; Wang X; Zhang J; Xie D; Pu Y
J Pharm Biomed Anal; 2024 Aug; 245():116167. PubMed ID: 38663257
[TBL] [Abstract][Full Text] [Related]
2. 1H-NMR-based metabolomics to dissect the traditional Chinese medicine promotes mesenchymal stem cell homing as intervention in liver fibrosis in mouse model of Wilson's disease.
Ma Y; Bao Y; Wang H; Jiang H; Zhou L; Yang B; Huang X; Yang W; Xie D; Zhang J
J Pharm Pharmacol; 2024 Jun; 76(6):656-671. PubMed ID: 38429940
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature.
Sarode GV; Kim K; Kieffer DA; Shibata NM; Litwin T; Czlonkowska A; Medici V
Metabolomics; 2019 Mar; 15(3):43. PubMed ID: 30868361
[TBL] [Abstract][Full Text] [Related]
4. A metabolic mechanism analysis of Fuzheng-Huayu formula for improving liver cirrhosis with traditional Chinese medicine syndromes.
Song YN; Chen J; Cai FF; Lu YY; Chen QL; Zhang YY; Liu P; Su SB
Acta Pharmacol Sin; 2018 Jun; 39(6):942-951. PubMed ID: 29072258
[TBL] [Abstract][Full Text] [Related]
5. 1H NMR-based metabolomics investigation of copper-laden rat: a model of Wilson's disease.
Xu J; Jiang H; Li J; Cheng KK; Dong J; Chen Z
PLoS One; 2015; 10(4):e0119654. PubMed ID: 25849323
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic profiling of Wilson disease, an inherited disorder of copper metabolism, and diseases with similar symptoms but normal copper metabolism.
Qiu Y; Su M; Xiao X; Zhou D; Xie L
Orphanet J Rare Dis; 2023 Sep; 18(1):282. PubMed ID: 37697371
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic and biochemical changes in the plasma and liver of toxic milk mice model of Wilson disease.
Liu Q; Wu X; Liu C; Wang N; Yin F; Wu H; Cao S; Zhao W; Wu H; Zhou A
J Pharm Biomed Anal; 2024 Aug; 246():116255. PubMed ID: 38795427
[TBL] [Abstract][Full Text] [Related]
8. [Study on relationship between Arg778Leu/Gln gene mutation spot in ATP7B and TCM syndrome type in Chinese patients with Wilson disease].
Yang B; Hu JY; Hong MF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Apr; 22(4):280-2. PubMed ID: 12584791
[TBL] [Abstract][Full Text] [Related]
9. Hepatic features of Wilson disease.
Boga S; Ala A; Schilsky ML
Handb Clin Neurol; 2017; 142():91-99. PubMed ID: 28433114
[TBL] [Abstract][Full Text] [Related]
10.
Pu Y; Zhang J; Peng N; Li R; Xie DJ; Zhang RX; Sun LT; Wang JL; Ye H
J Pharm Biomed Anal; 2023 May; 229():115355. PubMed ID: 37018958
[TBL] [Abstract][Full Text] [Related]
11. Wilson disease: histopathological correlations with treatment on follow-up liver biopsies.
Cope-Yokoyama S; Finegold MJ; Sturniolo GC; Kim K; Mescoli C; Rugge M; Medici V
World J Gastroenterol; 2010 Mar; 16(12):1487-94. PubMed ID: 20333789
[TBL] [Abstract][Full Text] [Related]
12. Serum metabolomics model and its metabolic characteristics in patients with different syndromes of dyslipidemia based on nuclear magnetic resonance.
Chen J; Ye C; Hu X; Huang C; Yang Z; Li P; Wu A; Xue X; Lin D; Yang H
J Pharm Biomed Anal; 2019 Apr; 167():100-113. PubMed ID: 30763881
[TBL] [Abstract][Full Text] [Related]
13. Iron metabolism and the role of HFE gene polymorphisms in Wilson disease.
Pfeiffenberger J; Gotthardt DN; Herrmann T; Seessle J; Merle U; Schirmacher P; Stremmel W; Weiss KH
Liver Int; 2012 Jan; 32(1):165-70. PubMed ID: 22098612
[TBL] [Abstract][Full Text] [Related]
14. Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis.
Zhong HJ; Sun HH; Xue LF; McGowan EM; Chen Y
World J Gastroenterol; 2019 Jan; 25(3):378-387. PubMed ID: 30686905
[TBL] [Abstract][Full Text] [Related]
15. Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers.
Mordaunt CE; Kieffer DA; Shibata NM; Członkowska A; Litwin T; Weiss KH; Zhu Y; Bowlus CL; Sarkar S; Cooper S; Wan YY; Ali MR; LaSalle JM; Medici V
Epigenetics Chromatin; 2019 Feb; 12(1):10. PubMed ID: 30709419
[TBL] [Abstract][Full Text] [Related]
16. The blood copper isotopic composition is a prognostic indicator of the hepatic injury in Wilson disease.
Lamboux A; Couchonnal-Bedoya E; Guillaud O; Laurencin C; Lion-François L; Belmalih A; Mintz E; Brun V; Bost M; Lachaux A; Balter V
Metallomics; 2020 Nov; 12(11):1781-1790. PubMed ID: 33057522
[TBL] [Abstract][Full Text] [Related]
17. A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson Disease.
Greig JA; Nordin JML; Smith MK; Ashley SN; Draper C; Zhu Y; Bell P; Buza EL; Wilson JM
Hum Gene Ther Clin Dev; 2019 Mar; 30(1):29-39. PubMed ID: 30693797
[TBL] [Abstract][Full Text] [Related]
18. Uneven distribution of hepatic copper concentration and diagnostic value of double-sample biopsy in Wilson's disease.
Liggi M; Mais C; Demurtas M; Sorbello O; Demelia E; Civolani A; Demelia L
Scand J Gastroenterol; 2013 Dec; 48(12):1452-8. PubMed ID: 24164422
[TBL] [Abstract][Full Text] [Related]
19. Wilson disease.
Kitzberger R; Madl C; Ferenci P
Metab Brain Dis; 2005 Dec; 20(4):295-302. PubMed ID: 16382340
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the hepatoprotective effect of Corydalis saxicola Bunting on carbon tetrachloride-induced liver fibrosis in rats by
Liu XW; Tang CL; Zheng H; Wu JX; Wu F; Mo YY; Liu X; Zhu HJ; Yin CL; Cheng B; Ruan JX; Song FM; Chen ZN; Song H; Guo HW; Liang YH; Su ZH
J Pharm Biomed Anal; 2018 Sep; 159():252-261. PubMed ID: 29990893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
